JPWO2020218121A1 - - Google Patents
Info
- Publication number
- JPWO2020218121A1 JPWO2020218121A1 JP2021516037A JP2021516037A JPWO2020218121A1 JP WO2020218121 A1 JPWO2020218121 A1 JP WO2020218121A1 JP 2021516037 A JP2021516037 A JP 2021516037A JP 2021516037 A JP2021516037 A JP 2021516037A JP WO2020218121 A1 JPWO2020218121 A1 JP WO2020218121A1
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4723—Cationic antimicrobial peptides, e.g. defensins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
- G01N33/57585—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites involving compounds identifiable in body fluids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
- G01N33/532—Production of labelled immunochemicals
- G01N33/535—Production of labelled immunochemicals with enzyme label or co-enzymes, co-factors, enzyme inhibitors or enzyme substrates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/035—Fusion polypeptide containing a localisation/targetting motif containing a signal for targeting to the external surface of a cell, e.g. to the outer membrane of Gram negative bacteria, GPI- anchored eukaryote proteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
- C07K2319/43—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation containing a FLAG-tag
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
- G01N2333/4701—Details
- G01N2333/4721—Cationic antimicrobial peptides, e.g. defensins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2470/00—Immunochemical assays or immunoassays characterised by the reaction format or reaction type
- G01N2470/04—Sandwich assay format
- G01N2470/06—Second binding partner specifically binding complex of analyte with first binding partner
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2019082912 | 2019-04-24 | ||
| JP2019082912 | 2019-04-24 | ||
| PCT/JP2020/016607 WO2020218121A1 (ja) | 2019-04-24 | 2020-04-15 | 癌を検出する方法および検出試薬 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JPWO2020218121A1 true JPWO2020218121A1 (https=) | 2020-10-29 |
| JPWO2020218121A5 JPWO2020218121A5 (https=) | 2023-04-24 |
| JP7546255B2 JP7546255B2 (ja) | 2024-09-06 |
Family
ID=72942515
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021516037A Active JP7546255B2 (ja) | 2019-04-24 | 2020-04-15 | 癌を検出する方法および検出試薬 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20220178932A1 (https=) |
| EP (1) | EP3960758A4 (https=) |
| JP (1) | JP7546255B2 (https=) |
| CN (1) | CN113727995A (https=) |
| WO (1) | WO2020218121A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7661767B2 (ja) * | 2021-04-28 | 2025-04-15 | 東ソー株式会社 | 細胞外小胞の検出方法 |
| JPWO2024203968A1 (https=) * | 2023-03-24 | 2024-10-03 | ||
| WO2025197993A1 (ja) * | 2024-03-22 | 2025-09-25 | 学校法人東邦大学 | テトラスパニン１０陽性細胞外小胞の濃縮方法、及びがんを検出する又はがんの予後を予測する方法 |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20120077695A1 (en) * | 2010-09-27 | 2012-03-29 | Somalogic, Inc. | Mesothelioma Biomarkers and Uses Thereof |
| US20140045915A1 (en) * | 2010-08-31 | 2014-02-13 | The General Hospital Corporation | Cancer-related biological materials in microvesicles |
| US20150141273A1 (en) * | 2012-04-26 | 2015-05-21 | Stichting Vu-Vumc | Biomarkers |
| US20170153240A1 (en) * | 2015-11-30 | 2017-06-01 | Sungkwang Medical Foundation | Composition, kit, and method for diagnosing and treating ovarian cancer |
| WO2018079689A1 (ja) * | 2016-10-28 | 2018-05-03 | 公益財団法人がん研究会 | バイオマーカー、疾患関連遺伝子の探索方法、及び腎がんマーカー |
| WO2018217087A1 (en) * | 2017-05-23 | 2018-11-29 | Stichting Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis | Novel stool-based protein biomarkers for colorectal cancer screening |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1502522A (en) | 1976-11-25 | 1978-03-01 | Gestetner Ltd | Stencil ejector on a stencil duplicator |
| GB0711327D0 (en) | 2007-06-12 | 2007-07-25 | Hansa Medical Ab | Diagnostic method |
| JP5663834B2 (ja) | 2008-03-14 | 2015-02-04 | 東ソー株式会社 | 遺伝子組換え抗体の製造方法 |
| JP5488885B2 (ja) | 2009-10-28 | 2014-05-14 | 国立大学法人 東京大学 | 感染症の疾患マーカー |
| KR20140107615A (ko) * | 2011-12-26 | 2014-09-04 | 시오노기 앤드 컴파니, 리미티드 | 엑소좀 검출용 모노클로날 항체 |
| WO2015083791A1 (ja) * | 2013-12-04 | 2015-06-11 | 国立研究開発法人理化学研究所 | 肺癌の検出方法および検出キット |
| KR102582192B1 (ko) | 2014-12-05 | 2023-09-25 | 후지필름 가부시키가이샤 | Tim 단백질 결합 담체, 당해 담체를 사용한 세포외막소포 및 바이러스의 취득 방법, 제거 방법, 검출 방법 그리고 당해 담체를 포함하는 키트 |
| CN115047182B (zh) * | 2017-10-05 | 2025-03-11 | 香港科技大学 | 外泌体分析及癌症诊断方法 |
-
2020
- 2020-04-15 WO PCT/JP2020/016607 patent/WO2020218121A1/ja not_active Ceased
- 2020-04-15 US US17/605,327 patent/US20220178932A1/en not_active Abandoned
- 2020-04-15 JP JP2021516037A patent/JP7546255B2/ja active Active
- 2020-04-15 EP EP20795091.6A patent/EP3960758A4/en active Pending
- 2020-04-15 CN CN202080030591.0A patent/CN113727995A/zh active Pending
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20140045915A1 (en) * | 2010-08-31 | 2014-02-13 | The General Hospital Corporation | Cancer-related biological materials in microvesicles |
| US20120077695A1 (en) * | 2010-09-27 | 2012-03-29 | Somalogic, Inc. | Mesothelioma Biomarkers and Uses Thereof |
| US20150141273A1 (en) * | 2012-04-26 | 2015-05-21 | Stichting Vu-Vumc | Biomarkers |
| US20170153240A1 (en) * | 2015-11-30 | 2017-06-01 | Sungkwang Medical Foundation | Composition, kit, and method for diagnosing and treating ovarian cancer |
| WO2018079689A1 (ja) * | 2016-10-28 | 2018-05-03 | 公益財団法人がん研究会 | バイオマーカー、疾患関連遺伝子の探索方法、及び腎がんマーカー |
| WO2018217087A1 (en) * | 2017-05-23 | 2018-11-29 | Stichting Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis | Novel stool-based protein biomarkers for colorectal cancer screening |
Non-Patent Citations (1)
| Title |
|---|
| JINGUSHI, KENTARO ET AL.: "Extracellular vesicles isolated from human renal cell carcinoma tissues disrupt vascular endothelial", INTERNATIONAL JOURNAL OF CANCER, vol. 142, JPN6020021845, 2018, pages 607 - 617, ISSN: 0005316484 * |
Also Published As
| Publication number | Publication date |
|---|---|
| EP3960758A4 (en) | 2023-02-15 |
| JP7546255B2 (ja) | 2024-09-06 |
| EP3960758A1 (en) | 2022-03-02 |
| WO2020218121A1 (ja) | 2020-10-29 |
| CN113727995A (zh) | 2021-11-30 |
| US20220178932A1 (en) | 2022-06-09 |
Similar Documents
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20211116 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20230414 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20230414 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20240507 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20240628 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20240806 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20240819 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 7546255 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |